Publication Name	World Journal of Clinical Oncology
Manuscript ID	8393
Country	Romania

Received	2013-12-28 11:29
Peer-Review Started	2013-12-28 15:04
First Decision by Editorial Office Director
Return for Revision	2014-01-20 17:46
Revised	2014-02-09 17:54
Publication Fee Transferred
Second Decision by Editor	2014-06-18 15:09
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-06-18 15:29
Articles in Press	2014-06-18 15:52
Edit the Manuscript by Language Editor	2014-07-01 22:33
Typeset the Manuscript	2014-07-18 10:14
Publish the Manuscript Online	2014-08-01 15:17

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pathology
Manuscript Type	Topic Highlights
Article Title	Significance of immunohistochemistry in breast cancer
Manuscript Source	Invited Manuscript
All Author List	Dana Carmen Zaha
Funding Agency and Grant Number
Corresponding Author	Dana Carmen Zaha, MD, PhD, Lecturer,Preclinical Department, Faculty of Medicine and Pharmacy,Oradea University, 1 December Square, No.10, Oradea 410087,Romania. danazaha @rdslink.ro
Key Words	Breast cancer; Immunohistochemistry; Markers
Core Tip	Immunohistochemistry has an important role in the pathology of breast disease, as well as in other benign or malignant tumours. There is a growing list of available products (antibodies) or antigen retrieval techniques, which all contribute to the broader utility of immunohistochemistry for solving diagnostic problems or for determining prognosis and response to therapy in breast pathology. Myoepithelial markers are useful in helping to distinguish benign lesions from malignant lesions. The most common immunohistochemical breast cancer prognostic and therapeutic markers used include: estrogen receptor, human epidermal growth factor receptor-2, Ki-67, progesterone receptor, and p53. In addition, markers of angiogenesis and apoptosis are also important.
Publish Date	2014-08-01 15:17
Citation	Zaha DC. Significance of immunohistochemistry in breast cancer. World J Clin Oncol 2014; 5(3): 382-392
URL	http://www.wjgnet.com/2218-4333/full/v5/i3/382.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i3.382

Full Article (PDF)	WJCO-5-382.pdf
Full Article (Word)	WJCO-5-382.doc
Manuscript File	8393-Review.docx
Answering Reviewers	8393-Answering reviewers.pdf
Copyright License Agreement	8393-Copyright assignment.pdf
Peer-review Report	8393-Peer reviews.pdf
Scientific Misconduct Check	8393-CrossCheck.jpg
Scientific Editor Work List	8393-Scientific editor work list.pdf